Actively Recruiting
Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation
Led by john eisenbrey · Updated on 2026-02-17
210
Participants Needed
1
Research Sites
251 weeks
Total Duration
On this page
Sponsors
J
john eisenbrey
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This phase II trial studies how well contrast-enhanced ultrasound (CEUS) works for diagnosing patients with renal cell cancer (RCC) that has come back (recurrent) after an ablation. Diagnostic imaging, such as CEUS, may help find and monitor long term renal cell cancer recurrence following cryo or microwave ablation.
CONDITIONS
Official Title
Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Previously received cryotherapy or microwave therapy of renal cell carcinoma
- Have contrast-enhanced MRI or CT imaging available prior to ablation
- Have had or are scheduled for contrast-enhanced MRI/CT within 4 weeks of the CEUS study
- Be at least 18 years old
- Be medically stable
- If female of child-bearing age, have a negative pregnancy test
- Signed informed consent to participate in the study
You will not qualify if you...
- Medically unstable or seriously/terminally ill patients with unpredictable clinical course
- Known sensitivities to components of Lumason
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107
Actively Recruiting
Research Team
J
John Eisenbrey, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here